Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart
  • Log out

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries

Francesco Blasi, Alberto Matteelli, Giovanni Sotgiu, Daniela Maria Cirillo, Fabrizio Palmieri, Lanfranco Fattorini, Giovanni Battista Migliori
European Respiratory Journal 2017 49: 1602242; DOI: 10.1183/13993003.02242-2016
Francesco Blasi
1Dept of Pathophysiology and Transplantation, Università degli Studi di Milano, IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alberto Matteelli
2Clinic of Infectious and Tropical Diseases, University of Brescia and Brescia Spedali Civili General Hospital, WHO Collaborating Centre for TB/HIV and TB Elimination, Brescia, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Sotgiu
3Clinical Epidemiology and Medical Statistics Unit, Dept of Biomedical Sciences, University of Sassari - Research, Medical Education and Professional Development Unit, AOU Sassari, Sassari, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanni Sotgiu
Daniela Maria Cirillo
4Emerging Bacterial Pathogens Unit, WHO collaborating Centre and TB Supranational Reference laboratory, San Raffaele Scientific institute, Milan, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabrizio Palmieri
5Respiratory Infectious Diseases Unit, National Institute for Infectious Diseases ‘L. Spallanzani’, IRCCS Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lanfranco Fattorini
6Dept of Infectious, Parasitic and Immune-Mediated Diseases, Italian National Institute of Health, Rome, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Giovanni Battista Migliori
7World Health Organization Collaborating Centre for Tuberculosis and Lung Diseases, Maugeri Institute, IRCCS Tradate, Tradate, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Giovanni Battista Migliori
  • For correspondence: giovannibattista.migliori@fsm.it
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Abstract

Consensus document to advocate and ensure proper implementation of WHO recommendations on TB elimination in Italy http://ow.ly/BHJC307S2U4

In 2014 the World Health Assembly endorsed the new End Tuberculosis Strategy that aims at reducing the global incidence of the disease by 90% within 2035 [1].

The World Health Organization (WHO) published, in 2015, a framework for tuberculosis (TB) elimination, e.g. a roadmap on how to reach TB elimination (less than one TB case per million population) in low TB incidence countries (those where TB incidence is lower than 10 cases per 100 000 population) [2]. The document had been jointly promoted by WHO and the European Respiratory Society in Rome in July 2014, followed by a consultation with representatives of low TB incidence countries and partner organisations. In this editorial, we present a roadmap for Italy which could also be used as a model for other low TB incidence countries in Europe.

In order to reach TB elimination by 2050, Italy first needs to lower TB incidence to reach the TB pre-elimination threshold (<10 cases per million population) by 2035 [2].

Over the past 70 years, TB incidence (as derived from TB notifications) in Italy has remained rather stable at around seven cases per 100 000 population [3], or 70 cases per million inhabitants. The rapid decline of TB cases among native Italians and the slower decline among foreign-born individuals has slowly modified the epidemiology of TB in Italy. According to a survey done by Istituto Superiore di Sanità, Rome (unpublished data), aimed at ensuring quality control in reference laboratories, out of 13 030 strains examined between 2008 and 2014, 47% belonged to native Italians (6161) and 53% to foreign-born individuals (6869). Interestingly, out of 410 multidrug-resistant TB (MDR-TB) strains, 77 were identified among native Italians (19%) and 333 among foreign-born individuals (81%).

In Italy and other low TB incidence countries in Europe, the goal of TB elimination is plausible [2]; it requires that the Ministry of Health identifies priority interventions and promotes a budgeted national plan for TB control and elimination with appropriate indicators [4–6].

Mathematical modelling indicates that, in order to reach TB elimination by the fixed deadline, the present annual incidence decline in Europe (2–5%) should gradually increase to approach the level of 20% [2, 3, 7]. According to WHO, this is possible if available prevention, diagnostic and treatment weapons are optimally implemented [2, 8, 9]. These include new generation rapid diagnostics and shorter regimens to treat TB disease (including its resistant forms) and latent TB infection (LTBI) [10, 11].

Examples are available of settings where an “aggressive approach”, based on TB control and elimination interventions, resulted in a rapid reduction in the incidence of TB and an advance towards the pre-elimination phase [12, 13].

This consensus (and call for action) document is aimed at promoting discussion between TB experts, administrators and policymakers in order to ensure that WHO recommendations on TB elimination are implemented in Italy.

In agreement with the principles of the TB elimination framework, we summarise eight core interventions and activities to be included in a roadmap for TB elimination in Italy, which were developed by consensus of representatives of different Italian and international organisations (including the European Respiratory Society) in a meeting organised by the Italian Respiratory Society (SIP/IRS) in Milan on October 5, 2016 (table 1).

  • 1) Political commitment with quality anti-TB services. TB control in Italy is presently based on 21 regional plans, which are not necessarily consistent among themselves and with the latest WHO policy documents. The main areas for further work are the management of LTBI and the use of rapid diagnostic tests outside reference centres. TB control and elimination activities need to be adequately funded.

  • 2) Improvement of surveillance allowing quality monitoring and evaluation of the programme. Italy should optimise its capacity to submit complete surveillance data to WHO and the European Centre for Disease Prevention and Control in a timely manner, while implementing a consistent plan for national molecular epidemiological surveillance.

  • 3) Focus on groups at higher risk of developing TB. A periodic identification of the groups where targeting TB elimination efforts is necessary, based on surveillance data.

  • 4) Development of a plan to manage migration-related issues. The number of TB cases among foreign-born individuals has increased and is, today, higher than that of native Italians. In addition, the important migration flow to Europe via land or sea (Italy is among the main migrants' host countries) needs a coherent and coordinated approach [14–16].

  • 5) Prioritisation of LTBI testing and treatment in high-risk groups. Diagnosis and treatment of LTBI is the core intervention needed to achieve TB elimination, as it will reduce the “reservoir” of infected individuals from which future cases will be generated [2].

  • 6) Prevention and treatment of MDR-TB. Although the absolute number of these cases is not high [17], the complexity and costs of their management, and the potentialities for further nosocomial transmission, call for a targeted approach [2]. Treatment outcome monitoring of MDR-TB should be implemented.

  • 7) Fostering of research on new vaccines, diagnostics and drugs. Italy needs to contribute to the global effort towards the acquisition of basic knowledge leading to the development of new anti-TB tools (basic research) and on their optimal implementation (implementation research).

  • 8) Global and European coordination of TB elimination efforts. It is common experience that TB does not respect borders and the best way to maintain future generations of TB experts is to actively cooperate in international TB control and elimination activities.

View this table:
  • View inline
  • View popup
TABLE 1

Summary of the main interventions to eliminate tuberculosis (TB) in Italy

We are confident that TB elimination can be within reach if Italy, together with the other low TB incidence countries in and outside Europe, will seriously embark in a comprehensive plan that incorporates all the core activities discussed above.

Footnotes

  • Conflict of interest: None declared.

  • The views and opinions expressed in this document are those of the authors and do not necessarily reflect the views and opinions of their institutes.

  • Received November 14, 2016.
  • Accepted December 5, 2016.
  • Copyright ©ERS 2017

References

  1. ↵
    World Health Organization. 67th World Health Assembly. Global Strategy and Targets for Tuberculosis Prevention, Care and Control After 2015. A67/11. Geneva, World Health Organization, 2014.
  2. ↵
    1. Lönnroth K,
    2. Migliori GB,
    3. Abubakar I, et al.
    Towards tuberculosis elimination: an action framework for low-incidence countries. Eur Respir J 2015; 45: 928–952.
    OpenUrlAbstract/FREE Full Text
  3. ↵
    Ministero della salute, Istituto superiore di sanità, Agenzia sanitaria e sociale della Regione Emilia-Romagna. RAPPORTO La Tubercolosi in Italia. Anno 2008. www.salute.gov.it/imgs/C_17_pubblicazioni_1222_allegato.pdf Date last accessed: November 11, 2016.
  4. ↵
    1. D'Ambrosio L,
    2. Dara M,
    3. Tadolini M, et al.
    Tuberculosis elimination: theory and practice in Europe. Eur Respir J 2014; 43: 1410–1420.
    OpenUrlAbstract/FREE Full Text
    1. Diel R,
    2. Loddenkemper R,
    3. Zellweger JP, et al.
    Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination. Eur Respir J 2013; 42: 785–801.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Ministero della Salute. Controllo della tubercolosi: obiettivi di salute, standard e indicatori – 2013–2016”, Roma 2012. www.salute.gov.it/imgs/C_17_pubblicazioni_1903_allegato.pdf Date last accessed: November 11, 2016.
  6. ↵
    World Health Organization. Global Tuberculosis Report 2016. WHO/HTM/TB/2016.13. Geneva, World Health Organization, 2016.
  7. ↵
    1. Migliori GB,
    2. Lienhardt C,
    3. Weyer K, et al.
    Ensuring rational introduction and responsible use of new TB tools. Outcome of an ERS multi-sectoral consultation. Eur Respir J 2014; 44: 1412–1417.
    OpenUrlFREE Full Text
  8. ↵
    World Health Organization. Implementing The End TB Strategy: The Essentials. WHO/HTM/TB/2015.31. Geneva, World Health Organization, 2015.
  9. ↵
    World Health Organization. WHO treatment guidelines for drug-resistant tuberculosis. 2016 update WHO/HTM/TB/2016.04. Geneva, World Health Organization, 2016.
  10. ↵
    1. Getahun H,
    2. Matteelli A,
    3. Abubakar I, et al.
    Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J 2015; 46: 1563–1576.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    1. Grzybowski S,
    2. Styblo K,
    3. Dorken E
    . Tuberculosis in Eskimos. Tubercle 1976; 57: Suppl. 4, S1–S58.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Voniatis C,
    2. Migliori GB,
    3. Voniatis M, et al.
    Tuberculosis elimination: dream or reality? The case of Cyprus. Eur Respir J 2014; 44: 543–546.
    OpenUrlFREE Full Text
  13. ↵
    UNHCR - The UN Refugee Agency. Refugees and migrants crossing the Mediterranean to Europe. Overview of arrival trends as of November 10, 2016. http://data.unhcr.org/mediterranean/regional.php. Date last accessed: November 11, 2016.
    1. Dara M,
    2. Solovic I,
    3. Sotgiu G, et al.
    Statement of the European Respiratory Society (ERS) and the European Region of the International Union Against TB and Lung Disease (The Union): call for urgent actions to ensure access to early diagnosis and care of TB among refugees. Eur Respir J 2016; 47: 1345–1347.
    OpenUrlAbstract/FREE Full Text
  14. ↵
    1. Dara M,
    2. Solovic I,
    3. Sotgiu G, et al.
    Tuberculosis care among refugees arriving in Europe: a ERS/WHO Europe Region survey of current practices. Eur Respir J 2016; 48: 808–817.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    1. Fattorini L,
    2. Mustazzolu A,
    3. Borroni E, et al.
    Tuberculosis in migrants from 106 countries, 2008–2014. Eur Respir J 2016; 47: 1273–1276.
    OpenUrlAbstract/FREE Full Text
    1. Blasi F,
    2. Dara M,
    3. van derWerf MJ, et al.
    Supporting TB clinicians managing difficult cases: the ERS/WHO Consilium. Eur Respir J 2013; 41: 491–494.
    OpenUrlFREE Full Text
PreviousNext
Back to top
View this article with LENS
Vol 49 Issue 2 Table of Contents
European Respiratory Journal: 49 (2)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries
Francesco Blasi, Alberto Matteelli, Giovanni Sotgiu, Daniela Maria Cirillo, Fabrizio Palmieri, Lanfranco Fattorini, Giovanni Battista Migliori
European Respiratory Journal Feb 2017, 49 (2) 1602242; DOI: 10.1183/13993003.02242-2016

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Moving towards tuberculosis elimination: a call for action from Italy and a possible model for other low tuberculosis incidence countries
Francesco Blasi, Alberto Matteelli, Giovanni Sotgiu, Daniela Maria Cirillo, Fabrizio Palmieri, Lanfranco Fattorini, Giovanni Battista Migliori
European Respiratory Journal Feb 2017, 49 (2) 1602242; DOI: 10.1183/13993003.02242-2016
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Respiratory infections and tuberculosis
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Towards a better mucolytic
  • Relationship between gastroesophageal reflux and pulmonary fibrosis
  • Artificial intelligence: do we need it for lung function interpretation?
Show more Editorials

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society